Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.

A randomized trial tested whether a ctDNA-guided approach could reduce adjuvant chemotherapy in stage II colon cancer without increasing recurrence. The abstract does not name the assay.

The New England Journal of MedicinePubMed 35657320DOI 10.1056/NEJMoa2200075